Related Experiment Videos
[Effectiveness and limits of D-penicillamine therapy]
T Behrend1, C Eisterhues, M Behrend
1Abt. für Rheumatologie und Balneologie der Medizinischen Hochschule Hannover im Staatsbad Nenndorf.
Zeitschrift Fur Rheumatologie
|January 1, 1988
Summary
Early use of dipropylacetic acid (DPA) in rheumatoid arthritis patients showed better efficacy. Long-term DPA treatment suggests sustained benefits, particularly when initiated early in the disease course.
Area of Science:
- Rheumatology
- Pharmacology
Context:
- Rheumatoid arthritis (RA) management involves long-term therapies.
- Assessing the long-term efficacy and predictors of response to dipropylacetic acid (DPA) in RA patients is crucial.
Purpose:
- To evaluate the long-term effects of dipropylacetic acid (DPA) in rheumatoid arthritis patients.
- To identify factors influencing treatment response and long-term outcomes.
Summary:
- A study of 68 rheumatoid arthritis patients treated with DPA indicated that early initiation of therapy leads to more favorable outcomes.
- While initial improvement was observed in 54 patients after one year, sustained efficacy varied, with optimal early response predicting long-term benefit.
- Patients unresponsive to DPA often had longer disease duration and prior treatment failures, suggesting therapy resistance.
Impact:
- Early DPA treatment in RA may improve patient outcomes.
- Identifying non-responders early can guide alternative treatment strategies.
- Findings contribute to understanding long-term DPA efficacy in rheumatoid arthritis.